`
`Merck Exhibit 2129, Page 1
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 1
`Mylan v. Merck, IPR2020-00040
`
`
`
`Merck Exhibit 2129, Page 2
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 2
`Mylan v. Merck, IPR2020-00040
`
`
`
`REQUESTFOR ANALYSIS
`sere een
`
`— Bad (67Fo02|CLOMUU 6130-313 [Oras
`
`PPCL # /
`
`.
`
`NOTEBOOK OR BATCH #
`
`PROJECT #¥
`
`EXT
`
`SAMPLE DISPOSITION
`
`‘
`
`MOLECULAR WEIGHT
`
`{SENO REPORT TO
`
`AREA
`
`DATE
`
`<
`
`‘SUBMITTED BY
`
`&
`
`0
`OMPLETE STRUCTURE
`
`{ JRETAIN[ JRETURN [ JDISCARD
`*
`
`CHEMICAL NAME
`
`o
`
`' Boc - amine amide
`
` ML'S
`
`OTHER TESTS AND COMMENTS
`
`
`
`
`
`UV
`
`SPECIFIC
`SIDUE
`MELTING
`ON
`ROTATION
`
`POINT
`
`
`IGNITION
`
`
`
`
`|_|
`
`.
`
`
`
`ANALYSIS PSA’ | DSC|| TG a |_| TLC | BULK a MESH a ALL
`
`CONTROLS
`
`pover rscnen F aouts [Tone
`
`
`SOLUTION
`
`
`
`
`
`
`ANALYSIS
`
`.
`
`
`
`CHN
`
`
`
`DO
`
`NOT
`
`WRITE
`
`BELOW
`
`THIS
`
`LINE
`
`RESULTS
`
`ccm
`
`aT
`731
`EO
`nN
`as
`
`14.90
`
`14.87
`
`Ib A
`
`14.06
`44S
`
`Acta ‘b
`N.47%
`6. LO
`O13
`oN
`
`OOr
`
`101
`
`rE: 6%
`
`VA
`U6
`
`7
`
`.
`
`,
`
`PP LAB PROCF
`
`ANALYST
`
`pe[Sep ea ah awe
`
`DATE
`
`Merck Exhibit 2129, Page 3
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 3
`Mylan v. Merck, IPR2020-00040
`
`
`
`Rene we
`
`OATE .
`.
`.
`Sy
`San 30.2000
`SUBMITTED BY
`
`OMPLETE STRUCTURE
`
`,
`
`e
`
`.
`
`¥
`
`“REQUEST FOR ANALYSIS. 0°:
`
`PPCL a
`
`:
`
`.
`
`.
`
`NOTEBOOK OR BATCH
`
`PROJECT #
`
`ExT
`
`SAMPLE DISPOSITION
`
`MOLECULAR WEIGHT
`
`SEND REPORT TO
`
`AREA
`
`LaneTAIN IRETURN [ JDISCARD
`|
`
`CHEMICAL NAME
`
`C-TUA1.US - O0OT OOS
`
`.
`
`{
`
`.
`
`EMPIRICAL FORMULA
`
`:
`
`OTHER TESTS AND COMMENTS
`
`TEST
`
`KARL
`
`TOTAL
`
`RESIDUE
`
`
`
`
`ON
`FISCHER [| SOLIDS
`ORYING
`UV a POINT
`|_| SRECIFIC
`LOSS ON
`(AELTING
`SPECIFIC
`
`
`
`
`
`
`
`
`IGNITION
`
`
`
`
`
`HEAVY_ CT - pee
`
`ALLa, att
`MESH
`
`psc
`
`TG
`
`X-RAY
`
`TLC
`
`BULK
`
`NOT
`
`WRITE
`
`BELOW
`
`THIS
`
`“RINE
`
`| [TITRATION
`
`
`
`nmcro| | psa
`|_|
`
`
`
`CHN
`
`|.
`
`RESULTS
`
`
`
`0.83
`
`0.43
`
`0 06
`
`OAs
`
`0.08
`0.44
`6.04%
`046 —
`hSO 44.6
`
`N,
`Toln| wp = 0.34
`
` PP LAB PROC. #
`pee Ea.
`[ee we
`
`ANALYST
`
`:
`
`DATE ——
`
`ae
`
`Merck Exhibit 2129, Page 4
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 4
`Mylan v. Merck, IPR2020-00040
`
`
`
`mere ay75
`
`REQUESTFOR ANALYSIS) *
`
`DATE
`Sule We
`SUBMITTED BY.
`
`OMPLETE STRUCTURE
`
`PPCL#
`
`NOTEBOOK OR BATCH #.
`
`PROJECT #
`
`SEND REPORT TO
`
`AREA
`
`SAMPLE DISPOSITION
`
`EMPIRICAL FORMULA
`
`MOLECULAR WEIGHT
`
`CHEMICAL NAME
`
`(yc—aminod anise
`
`~
`
`,
`
`OTHER TESTS AND COMMENTS
`
`KARL
`
`LOSS ON
`* TOTAL -
`
`
`SOLIDS
`DRYING
`
`
`HEAVY
`
`MELTING
`UV | POINT
`
`
`
`
`
` | [TITRATION
`FOo
`ateb DSC
`TG
`X-RAY |_|
`TLC
`
`SOLUTION
`
`
`
`
`CHN
`
`ANALYSIS
`
`
`DO
`
`NOT
`
`WRITE
`
`BELOW
`
`THIS
`
`
`
`
`RESIDUE
`SPECIFIC
`ON
`ROTATION
`
`
`IGNITION
`
`
`
`
`BULK
`
`LINE
`
`MESH a ALL
`
`Mest
`
`CONTROLS|
`
`RESULTS
`
`c
`
`Tina
`qu
`4.87
`Ud
`gM
`(VI
`BB
`49
`\q.63
`
`CiX-
`Or
`Ov
`0-74
`054
`ol
`;
`oa
`00 +,
`1-337
`
`
`
`Aca
`0.09 %
`~ 6%
`5.06“
`91h
`o.U\b .
`9.0% ‘ts
`as o1%
`0.05 &
`
`Talal vmp> AGS
`
`‘
`
`°
`
`~
`
`PP LAB PROC. #7
`
`ANALYST
`
`OATE
`
`|
`
`TOD...
`
`Fett2tg
`
`Merck Exhibit 2129, Page 5
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 5
`Mylan v. Merck, IPR2020-00040
`
`
`
`- MERCK & CO., INC.
`R827-L 4/75,
`OATE
`
`Tau lo.2002
`
`” SUBMITTED BY
`
`OMPLETE STRUCTURE
`1
`
`t
`
`REQUEST FOR ANALYSIS
`
`PPCL#
`
`NOTEBOOK OR BATCH #
`
`PROJECT #
`
`7ois0-347 [eas
`[neva peinacaCHEMICAL NAME
`
`SAMPLE DISPOSITION
`
`MOLECULAR WEIGHT
`
`SEND REPORT TO
`
`EXT
`
`AREA
`
`Regvatk ~saH ECan TPAC
`
`\
`
`-
`
`;
`
`EMPIRICAL FORMULA
`JN
`
`.
`
`‘
`
`OTHER TESTS ANO COMMENTS
`
`TOTAL
`
`LOSS ON
`DRYING
`
`
`
`
`
`
`SPECIFIC
`
`
`
`, MELTING
`ROTATION
`\POINT~
`
`
`IGNITION
`
`
`PSA a
`
`
`
`ANALYSIS
`
`
`CHN
`
`TG a X-RAY | TLC | BULK | MESH | ALL
`
`ANALYSIS|CONTROLS
`
`
`
`oo
`
`NOT
`
`WRITE
`
`BELOW
`
`THIS
`
`LINE
`
`
`
`RESULTS
`
`ae
`
`,
`
`Time
`
`CAT
`
`
`Area bo
`
`”
`
`VAN
`WA
`
`(1.23
`
`UB613
`
`0.1
`044
`
`1.00
`
`3s
`
`0.36%
`0.25 (Group oF pwrs)
`
`ay.Wb
`
`0.65 %
`
`?
`
`%
`
`NF
`
`r
`
`DATE -
`
`PP LAB PROC #
`TON
`Cub U.2wr
`
`
`
`
`
`
`
`Merck Exhibit 2129, Page 6
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 6
`Mylan v. Merck, IPR2020-00040
`
`
`
`T0321 Pycl
`TABLE OF CONTENTS
`(Please list keywords or subject information for each page orseries of pages)
`
`yee 4
`SAA _Aow * Oc eine 1.224715-NoR
`tet
`tr, Aca
`
`g
`
`r
`
`Leta}
`_
`
`~
`
`54
`v
`
`OoF
`
`LIAS -Tabak
`
`Lng 7e7a
`+/-
`
`‘ y Teal
`tr,
`L DAYS Preebrse Dea, L22qIS Beside .
`BUS
`m
`=)
`Nof
`|. EDC Het
`o
`IH
`2. TASe
`F
`Z,
`oF yes, ©
`st
`(2247)
`
`1. EDCHEN
`
`Ac(nae a. (2? C
`24
`Fue) ie
`
`LEANIE
`
`5
`5
`
`LGPhot
`
`Phoshabe
`
`[O35
`FE f
`We
`
`F
`
`O25
`
`Lns eS L224HSMPs,
`
`Pechaye
`
`Ee
`
`2
`
`.
`
`oat
`
`|. Brot Af
`LOZATIS~
`Ph SN 2. Tebawacd
`
`L22497/S5—
`Tae bent
`
`OAT | 2241S- wetMe
`122415
`Ph So, H
`;
`Besylak Lido
`YQ) C2ZzuI§
`1. Ersac/ Nop
`Ph 0. if ane LIR2YHs
`0%
`5 3
`a. K3Poy
`Paosplale
`0333 aa | Aca
`ix
`6PASS oaoe
`
`:
`.
`Ho% O
`LEDCIARN[Ninn = fFGow
`ee
`on
`feey
`- Hy wo
`ee
`
`
`
`.
`
`u
`O13
`(224115° at L224 Mose
`Acn[t20
`
`ot
`12247 IS | Ete| Minott
`Tortrnle > HPA
`
`£23097)7
`Pho yp ne
`
`
`
`vis
`
`FPa/ho
`
`olF
`
`Lr24HS
`
`H4Poy
`
`E4cd [ho
`
`LARdTISPhesphh
`
`+
`
`A a
`
`es
`
`
`
`
`Salt,
`
`63 j
`“
`Laad}is HaPey_,224718 Phophk
`ae
`Tet i.LERKranfoes©
`Lp
`wa
`F tove
`27 weey"sf
`a8
`lle
`
`us
`as eae
`lL EDCAcN a.
`3
`y+le
`2. Hy PAle
`
`014
`gays _#aPey sb 2aqy is foie
`erit[ H2°
`$ lew cocldayy
`
`02.1
`
`Lagi PREB-s Lads Phaphale
`
`wel
`
`- —
`frrsobn 0
`ff =f
`CLE Ayp EREtRCNy
`
`ie
`
`43
`6
`| TS Ayre
`wr
`‘
`
`| ED GNewNaw C2241K5-
`2. H>PA/c
`Hy Psy
`
`aS,
`
`it
`
`EDCEtshejNan regs6
`
`5
`
`
`le es Ac)Oe é
`
`
`Merck Exhibit 2129, Page 7
`Mylan.v. Merck, IPR2020-00040
`
`
`
`Merck Exhibit 2129, Page 7
`Mylan v. Merck, IPR2020-00040
`
`
`
`a
`On Iebrabiin FKeLcfar
`Burd Ammoared
`
`> MERCK
`TABLE OF CONTENTS
`(Please list keywords or subject information for each pageorseries of pages)
`yak_e ¥RBy © RyDey EDC
`1S Ar:AAett Nowa,
`Bb<ee LAQATISHeRay
`Seber
`ChF
`+2 TV St,ate 330owt PAK
`4 VISk,try Hote 27.Pfc
`croSPete "ey SAS peay mn
`Emer
`r
`vasck AN
`CFL $193 Prenat Bow Sconpluy ' redudy, Pedy:
`Ss A Brod »
`pecuniary
`.
`< K
`|
`rs +f‘O27
`YS" o eee
`EDCNe
`ts
`a “ —
`St aren
`oe meeeSmid Boat t
`|
`ArSSF,4
`1oe a pre
`Xt
`Rovik 0
`3
`Peart Ne
`“4
`\
`Pron 6
`¥4
`eX
`tape ww,
`oFer<Sroy 4 heh EDS,Nan AS s
`Ac
`Leie NaA
`d
`Pr +
`C
`“y —
`(ol:
`im
`nF
`‘a3 aoi1ametED.
`Mey
`ED Va
`~
`MyatogStadestude
`)
`Gd pBoot © t,
`IA/c
`ae
`Mee
`2 ty?
`TS L2RIFSHP, Omnt]s Pex - reseed
`bs Cul Geatisn oFGC
`jo—([s Rey hosecd
`At LAAVISHe Pay
`.
`lot
`Bont ©
`TA 622475 H,Po, Crysh Hien A.
`"OAs H fosRd/c Lads
`(Sy Low lh Ho
`émers
`lol L224 FISH»PO
`1 ase ys eeePAE Lays
`PAS
`elise
`os
`1
`J G
`lace,‘ys ursBarend rredy
`‘ a 0
`AeRy + Heytien E0c — x
`4 La Shuvddato fenaule EOCBsc
`A,
`bout
`Hee & MTBE 7
`oss
`12 rye
`|o+ arsod +4b-% shoe pdda do EVO trrrek
`eNLut AL (o7.edle
`|
`Po LrgchWed | 1 Oey we Pl,
`al kk
`Exo tk |
`:
`9 Host 67°C
`Oh
`
`So
`
`h-
`
`KL
`
`~~
`
`-
`
`iit
`
`i .25,t Uo
`
`1063 Laryrls HP,
`
`its.
`
`Merck Exhibit 2129, Page 8
`Mylan v. Merck, IPR2020-00040
`
`A
`
`Baont ©
`
`\
`
`—n
`
` Qoaddar
`
`a °
`
`ce
`
`KPnchsy
`
`Mme
`;
`
`
`
`
`
`Merck Exhibit 2129, Page 8
`Mylan v. Merck, IPR2020-00040
`
`
`
`.
`
`|
`
`7
`
`a
`
`‘Book .
`
`Page
`
`1
`
`Investigator
`
`2"
`
`O.920.[-1
`
`7031 6
`Project No.2AY7 = oo Project Page
`
`Date bfJo wn Dodd
`
`Subject
`(|,
`tase
`
`Filed in Book Number/Title
`
`F.
`L
`POD wn,
`t=I
`i po
`Cos nfs |
`Buo-Ammp Ae 72324-
`Airatole UU sl 72 (1-0se 2
`Epc
`An.
`ie Pare
`KON
`
`ASconor
`
`et 3.0 WG
`a = NALes thy
`Se
`8 et
`prnel
`24
`A—*
`Fus
`se
`[.0
`Sem
`PE 3A
`LEP RAN |
`yowet>
`Lb
`witty Lega2 LF
`(4.4
`ols opps peaiye
`Lo
`Smt
`
`Koo
`
`0.5m
`AAA Geom F Hoobs olebh AW The Added
`vedic? |.
`ope
`ooh
`cpu th Oo| Fur wake fe
`¢ Ec
`Add} 3 OPO dia dled
`Sbriat
`ma kin\
`ro last
`ers
`age
`Q-Sn~)
`wt |e
`| Eto...
`REE ropenrtnte > Thaker|
`Jor
`wt
`Ul,
`sat Nact,
`stoc|
`in TZ ep Wetted. PSo~ ASTA26E
`QVMund
`P
`3
`
`727,
`
`pte =
`
`Ladd
`
`yy
`~—-\
`She
`
`te
`S|
`
`A |
`A199 —
`[So~
`lo ~(
`
`(\
`
`AC
`
`ne d(
`
`r
`
`lA -
`
`Countersigned by °
`
`Date
`Merck Exhibit 2129,Pa sco in
`Bak 100} CMRL
`Mylan v. Merck, IPR20284
`
`Merck Exhibit 2129, Page 9
`Mylan v. Merck, IPR2020-00040
`
`
`
`Book
`
`t
`
`7031 6
`
`Page
`
`~?o
`
`Project No.__mnN.—ssS_ Project Page
`
`
`
`DO NOT BEGIN NEW EXPERIMENTSON THIS PAGE.
`
`BA
`
`W307. ee (Le
`
`YoPST “RT -
`A Ke sb.
`oPST soc
`lgeo~
`(ov. PAle .
`al
`apkk Lb
`Le Fi(hAa
`A weyskA sols
`ows NQ2. TIS, lan
`Bore,
`Ln
`brabe
`QJ
`aews
`whik bey Vion Doane
`
`He Md O N
`“pe ym 2eott
`thee
`snttr.
`tent
`2por 4 dow
`2a Ve
`.
`Ryn
`ry
`UOILCG os Sa
`Neb oduct
`ye.
`Ls salud
`D dsyeloek
`~ alan Teac £ cancetanbA
`set ALL [lnc
`Sct
`I, 1S 7
`2.
`ubvk
`esl
`
`
`
`
`A o.(TPACTaw arsly J Yh ath 1072, BL So, #- Hes
`
`Ve Lf AC he bed
`fe
`oO dt
`sed bak
`Clo ned
`Chomed
`4
`he
`Lis Br A
`HE _50C
`[bee KyolA
`For
`oR (Et hecd. West of TPA:
`ved
`Cee wih © YoC
`>
`
`(1. wtLQ24H6 Freee
`Ldghn>
`Laut Sey k
`vb c Mad.
`16 LtZ pec.
`Jan
`266Z—
`a
`GM
`-ACN Paks
`.D,
`ba
`cond
`Ui area
`Ss natin
`2002 Fe O{.
`FBO (Eb 002
`A
`Som TPAC
`NT te
`NMRL.
`colbchdl
` Crichl
`Jd tose
`Ebroe2-
`aoc Phys Meas. out mtiichsadualefaalabeal
`
`
`49
`V1 ee 4
`t a
`|, Hele Q
`s+
`U ACS Are Cnenhnr
`|
`;
`C-AbQ0L Clivtiean daeks AN khrlsore ome
`
`
`
`
`
`a
`
`FUR
`
`Hy al :
`
`aks
`
`acco
`
`DEN.
`
`|tllllllliit|llil|ll
`
`|MlIlllitil|ll —
`
`Date
`Merck Exhibit 2129, Page 10
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 10
`Mylan v. Merck, IPR2020-00040
`
`
`
`MERCK & CO.,.INC.,
`R827-L 4/75
`:
`
`REQU EST FOR ANALYSIS
`
`
`
`eeRn ol
`
`.
`
`PROJECT #
`|
`0726
`SEND REPORT TO
`
`,
`
`.:
`
`EXT
`
`.
`
`AREA
`
`NOTEBOOK OR BATCH #
`103/6- 00 |
`JMOLECULAR WEIGHT
`
`CHEMICAL NAME
`
`(-TUATS Besylat Salt
`
`OTHER TESTS AND COMMENTS
`
`.
`
`DATE
`a
`Tan 31.200
`Taw Sh
`SUBMITTED BY;
`\
`
`PPCL # :
`OOM”
`‘SAMPLE DISPOSITION
`
`—
`
`DMPLETE STRUCTURE
`
`>,
`
`EMPIRICAL FORMULA
`
` LOSS ON
`DRYING
`
`
`
`| pH
`
`
`— adSOLUTION
`
`
`
`
`ANALYSIS
`
`CHN
`
`RESULTS
`
`“©
`
`.
`
`
`
`| ALL
`| TLC
`ANALYSIS|CONTROLS
`
`
`psa
`
`|_|
`
`osc
`
`||
`
`ta |_].x-ray
`
`DO
`
`NOT
`
`-
`WRITE
`
`BELOW
`> ~
`
`THIS
`
`LINE
`
`ad
`
`°
`Arca,
`Kod
`© S67 0.06
`06S
`mn .
`Ye
`“au |
`190
`0.04
`1 OW
`ON
`Iyd
`bel swap = 0.64“be
`
`-
`
`|
`
`|
`
`.
`
`+
`
`Ciel
`
`oe
`_
`prqyar ewashrmn = FAV
`wast
`tumuhmatn >
`02
`Lee ask- (d<]104
`«
`.
`.
`NS }
`
`pe[sebbaron
`
`Merck Exhibit 2129, Page 11
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 11
`Mylan v. Merck, IPR2020-00040
`
`
`
`Hansen, Karl
`
`i
`
`Wap
`
`rom:
`ent:
`To:
`
`Karl,
`
`Dorwart, Jason G.
`Tuesday, February 05, 2002 11:13 AM
`Hansen, Karl
`
`Here are the results of the L-224715 Besylate salt NB# 70316-001.
`
`LCAP
`RRT
`0.65
`0.93
`0.95
`1.00
`1.04
`1.37
`
`Area %
`0.06%
`0.16%
`0.20%
`99.27%
`0.09%
`0.13%
`
`Chiral
`Major Enantiomer = 99.92%
`Minor Enantiomer = 0.08%
`
`ir
`
`ason
`
`Merck Exhibit 2129, Page 12
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 12
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\005-0101.D
`
`Sample Name: 70316-001
`
`0.1900g/50m1 of hydrog soln 17.85 g
`
`->
`
`Injection Date : 01/30/2002
`Sample Name
`: 70316-0001
`Acq Operator
`: hansen
`
`12:29:35 PM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile, 1ml/min
`
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`
`:
`:
`:
`
`l
`5
`1
`2 pl
`
`ML QAx, otHH a
`
`waters cl8 symmetry, 250 nm
`
`DAD1 C, Sig=210,8 Ref=360,100 (005-0101.D)
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`>: Signal
`: 01/14/2002
`> 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DAD1 C, Sig=210,8 Ref=360,100
`
`Peak
`+
`
`RT
`{min}
`
`Type Width Height
`(min)
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`.88 BB
`
`0
`0.082
`0.078
`
`0.083
`0.091
`0.201
`
`65.94
`30.31
`
`1.06
`2.62
`24.14
`
`.
`350.924
`149.939
`
`5.689
`15.583
`308.655
`
`.
`41.82
`17.87
`
`0.68
`1.86
`36.78
`
`0.00000C
`0.08999C
`0.00000C
`
`0.Q00000C
`0.00000C
`0.00000C
`
`L-224,715
`Benzy alert
`
`Signal:
`
`2 DAD1 E, Sig=268,16 Ref=360,100
`
`Peak
`#
`
`RT
`[min}
`
`Type Width Height
`(min)
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`5.55 BB
`1
`2 12.88 PB
`
`0.082
`0.204
`
`7.55
`1.86
`
`40.148
`24.616
`
`61.99
`38.01
`
`0.08999C
`0.00000C
`
`L-224,715
`
`HPLCO157
`
`01/30/2002
`
`12:43:56 PM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 13
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 13
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\098-0101.D
`
`Sample Name: 70316-001
`
`methanol soln of hydrog after
`
`Injection Date : 01/29/2002
`Sample Name
`: 70316-0001
`Acq Operator
`: hansen
`
`8:26:05 AM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`>: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`lml/min
`75/25 0.1% HC104/Acetonitrile,
`75/25 from 10 to 14 min
`10min 25/75 water/acn;
`waters cl8 symmetry, 250 nm
`
`©w
`
`oaw
`
`o
`
`DAD1 C, Sig=210,8 Ref=360,100 (098-0101.D)
`
`
`ooooooocoocooorqcoceomg/ml
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`Signal
`01/14/2002
`1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DAD] C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`(min)
`
`Type Width Height
`(min]
`
`Area
`
`[mAU*s]
`
`Amount
`
`2.28 BV
`1
`2.39 VB
`2
`2.96 BB
`3
`3.63 PB
`4
`5.55 BV
`5
`5.88 VV
`6
`6.13 VB
`7
`6.77 BB
`8
`7.46 PV
`9
`8.21 BV
`10
`8.35 VV
`11
`8.51 VP
`12
`9.90 BV
`13
`14 10.11 VB
`15 10.44 BB
`
`0.064
`0.074
`0.071
`0.080
`0.085
`0.078
`0.103
`0.080
`0.098
`0.099
`0.084
`0.085
`0.086
`0.116
`0.085
`
`ww NM oO
`
`rh
`
`000000
`.000000
`. 000000
`000000
`.276818
`.000000
`000000
`000000
`000000
`.000000
`-000000
`000000
`000000
`000000
`000000
`
`L-224,715
`
`HPLCO157
`
`01/29/2002
`
`Page 1 of 2
`Merck Exhibit 2129, Page 14
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 14
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`Peak
`#
`
`:C: \HPCHEM\HPLC0157\DATA\098-0101.D
`Area
`Area
`RT
`Type Width
`Height
`(min)
`(min]
`
`[mAU*s]
`
`%
`
`16 11.60 BB
`17 11.95 BV
`18 12.14 VB
`19 12.69 BV
`20 12.95 VV
`21 13.27 VV
`22 13.55 VB
`
`0.194
`0.105
`0.087
`0.123
`0.129
`0.185
`0.108
`
`3.70
`1.83e3
`8.67
`125.53
`58.48
`10.69
`
`33.466
`27.092
`9921.391
`76.832
`1132.982
`715.638
`79.096
`
`0.17
`0.13
`49.40
`0.38
`5.64
`3.56
`0.39
`
`. 000000
`000000
`. 000000
`000000
`000000
`000000
`.000000
`
`Signal:
`
`2 DAD1 E, Sig=
`
`268,16
`
`Ref=360,100
`
`Peak
`#
`
`RT
`{min]
`
`Type Width
`[min]
`
`Height
`
`Area
`(mAU*s]
`
`Area
`%
`
`566.822
`
`34.94
`
`5.55 BB
`1
`5.88 BB
`2
`6.77 BB
`3.
`4 12.14 BB
`5 12.97 VV
`6 13.27 VV
`7:13.55 VB
`
`0.082
`0.081
`0.082
`0.079
`0.175
`0.182
`0.104
`
`106.70
`5.96
`1.27
`173.36
`5.89
`5.19
`
`- 276818
`000000
`000000
`. 000000
`000000
`. 000000
`000000
`
`*** End of Report ***
`
`Sample Name: 70316-001
`Name
`
`L-224,715
`
`HPLCO157
`
`01/29/2002
`
`8:40:32 AM
`
`Page 2 of 2
`Merck Exhibit 2129, Page 15
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 15
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLC0157\DATA\099-0201.D
`
`Sample Name: 70316-001
`
`benzyl alcohol
`
`->
`
`8:44:40 AM
`
`Injection Date : 01/29/2002
`Sample Name
`: 70316-0001
`Acq Operator
`: hansen
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile,
`Iml/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`2
`:
`: 99
`:
`1
`:
`2 pl
`
`DAD1 C, Sig=210,8 Ref=360,100 (099-0201.D)
`
`mAU
`
`xa
`
`
`
`4
`2
`0
`DAD1 E, Sig=268,16 Ref=360,100 (099-0201 D)
`
`6
`
`8
`
`10
`
`12
`
`14
`
`min
`
`mAU
`
`600
`
`500
`400
`©
`300
`©
`+
`rs
`200
`iT9) pay o” N
`
`
`
`100
`o
`foo)
`x
`
`0 a
`
`0
`
`2
`
`4
`
`6
`
`8
`
`10
`
`12
`
`14
`
`min]
`
`Customized Report: karlo
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`: Signal
`: 01/14/2002
`: 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DADI C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`(min)
`
`Type Width Height
`([min]
`
`Area
`[mAU*s]}
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`3.54 BB
`1
`4.29 PB
`2
`0.00
`3.
`5.88 PB
`4
`6.68 BB
`5
`7.20 PP
`6
`8.34 BB
`7
`9.68 BP
`8
`9 10.88 BB
`10 11.73 BP
`11 13.00 BB
`12 14.28 VB
`
`11.170
`2.15
`0.081
`15.769
`3.05
`0.080
`0.000
`0.00
`0.000
`0.132 2.23e3 1.78624
`0.081
`37.91
`198.693
`0.072
`1.39
`6.156
`0.085 264.54 1423.633
`0.084
`6.80
`36.172
`0.115
`2.13
`16.999
`0.078
`42.61
`213.630
`0.239
`7.86
`127.571
`0.099 356.95 2238.477
`
`0.05
`0.07
`0.00
`80.64
`0.90
`0.03
`6.43
`0.16
`0.08
`0.96
`0.58
`10.11
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`HPLCO157
`
`01/29/2002
`
`8:59:07 AM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 16
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 16
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`>C: \HPCHEM\HPLCO157\DATA\099-0201.D
`Signal:
`2 DAD] E, Sig=268,16 Ref=360,100
`
`Peak
`#
`
`RT
`{min]
`
`Type Width
`{min}
`
`Height
`
`Area
`
`Area
`
`(mAU*s]
`
`%
`
`Sample Name: 70316-001
`
`0.00
`1
`5.88
`2
`6.68
`3
`8.34
`4
`5 14.28
`
`BB
`BB
`BB
`BB
`
`0.000
`0.078
`0.079
`0.085
`0.099
`
`L-224,715
`
`000000
`.000000
`000000
`.000000
`000000
`
`*** End of Report ***
`
`HPLCO157
`
`01/29/2002
`
`8:59:07 AM
`
`Page 2 of 2
`Merck Exhibit 2129, Page 17
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 17
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\009-0101.D
`
`Sample Name: 70316-001
`
`14.0mg/25ml of isolated besylate salt
`
`->
`
`: 70316-001
`
`: hansen
`
`6:59:40 AM
`
`Seq Line
`
`Vial No
`
`:
`
`:
`
`:
`
`l
`
`9
`
`1
`2 pl
`
`Injection Date : 01/31/2002
`
`oe: Name
`
`Acq Operator
`
`Inj. No.
`Inj. Vol.
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile, 1ml/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`DAD1 C, Sig=210,8 Ref=360,100 (009-0101.D)
`
`4
`2
`DAD1 E, Sig=268,16 Ref=360,100 (009-0101.D)
`
`
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`: Signal
`: 01/14/2002
`: 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DAD1 C, Sig=210,8 Ref=360, 100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`{min]
`
`Area
`(mAU*s]
`
`Area
`g
`
`Amount
`mg/ml
`
`Name
`
`2.48 VV
`1
`2.59 VB
`2
`5.52 BB
`3
`4 13.24 BP
`
`5.400
`1.70
`0.047
`837.035
`0.089 137.80
`0.082 276.52 1469.249
`0.195
`1.74
`20.490
`
`0.23
`35.89
`63.00
`0.88
`
`0.000000
`0.000000
`0.387022
`0.000000
`
`L-224,715 @4F
`
`Signal:
`
`2 DAD1 E, Sig=268,16 Ref=360,100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`{min]
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`2.59 BB
`1
`5.52 BB
`2
`3.13.26 PP
`
`0.088
`0.082
`0.215
`
`4.11
`31.93
`1.10
`
`24.614
`169.240
`14.711
`
`11.80
`81.15
`7.05
`
`0.000000
`0.387022
`0.000000
`
`L-224,715
`
`HPLC0157
`
`01/31/2002
`
`7:13:58 AM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 18
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 18
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\010-0101.D
`
`Sample Name: 70316-0011
`
`3.108g/50ml of 16.8g ML 's
`
`Injection Date : 01/31/2002
`Sample Name
`> 70316-0001
`Acq Operator
`: hansen
`
`9:16:19 AM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol:
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`lml/min
`75/25 0.1% HC104/Acetonitrile,
`75/25 from 10 to 14 min
`10min 25/75 water/acn;
`waters cl8 symmetry, 250 nm
`
`DAD1 C, Sig=210,8 Ref=360,100 (010-0107.D)
`
`
`
`
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`Signal
`01/14/2002
`1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DAD C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`(min]
`
`Area
`
`[mAU*s]
`
`2.39 VV
`1
`2.49 VV
`2
`2.60 VB
`3
`3.63 BB
`4
`5.05 PB
`5
`5.55 PV
`6
`5.88 VB
`7
`6.76 BB
`8
`7.82 BV
`9
`8.02 VV
`10
`8.33 VV
`11
`8.50 VB
`12
`9.27 VP
`13.
`9.89 BV
`14
`15 10.09 VB
`
`0.058
`0.042
`0.089
`0.082
`0.086
`0.083
`0.078
`0.084
`0.085
`0.092
`0.107
`0.082
`0.100
`0.087
`0.084
`
`NO > wn
`
`wo ~) hw
`
`w
`
`on
`
`oooocoooooo0oo0o0000
`
`. 000000
`000000
`000000
`000000
`000000
`- 124960
`000000
`000000
`. 000000
`000000
`000000
`000000
`000000
`000000
`000000
`
`L-224,715
`
`HPLCO157
`
`01/31/2002
`
`Page 1 of 2
`Merck Exhibit 2129, Page 19
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 19
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`Peak
`#
`
`:C:\HPCHEM\HPLC0O157\DATA\010-0101.D
`RT
`Type Width Height
`Area
`Area
`[min]
`[min]
`[mAU*s]
`%
`
`Amount
`mg/ml
`
`Sample Name: 70316-0011
`Name
`
`16 10.42 BB
`17 12.13 VB
`18 12.93 VB
`
`0.091
`0.092
`0.089
`
`45.48
`4.99
`7.43
`
`269.598
`30.715
`42.450
`
`3.53
`0.40
`0.56
`
`0.000000
`0.000000
`0.000000
`
`Signal:
`
`2 DAD] E, Sig=268,16 Ref=360,100
`
`Peak
`#
`
`RT
`{min]
`
`Type Width Height
`{min]
`
`Area
`{mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`5.05 BB
`1
`5.55 BB
`2
`5.88 BP
`3
`9.27 PP
`4
`5 10.09 PP
`6 10.42 BP
`
`0.087
`0.081
`0.083
`0.098
`0.088
`0.093
`
`1.62
`10.55
`5.50
`1.45
`1.00
`4.53
`
`9.085
`55.201
`29.482
`8.968
`5.712
`27.611
`
`6.68
`40.57
`21.67
`6.59
`4.20
`20.29
`
`0.000000
`0.124960
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`**x* End of Report ***
`
`HPLCO157
`
`01/31/2002
`
`9:30:35 AM
`
`Page 2 of 2
`Merck Exhibit 2129, Page 20
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 20
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\003-0101.D
`
`Sample Name: 70316-001
`
`hydrog after resubmission more concentrated
`
`->
`
`Injection Date : 01/30/2002
`Sample Name
`: 70316-0011
`Acq Operator
`: hansen
`
`8:54:32 AM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile, 1lml/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`1
`3
`1
`2 pl
`
`:
`:
`:
`
`DAD1 C, Sig=210,8 Ref=360,100 (003-0101.D)
`
`2
`
`4
`
`DAD1 E, Sig=268,16 Ref=360,100 (003-0101.D)
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`: Signal
`: 01/14/2002
`: 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DADI1 C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`[min]
`
`Area
`(mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`2.19 BV
`1
`2.26 VV
`2
`2.39 VV
`3.
`2.56 VB
`4
`2.96 BB
`5
`3.63 PB
`6
`5.04 BV
`7
`5.20 VP
`8
`5.54 BV
`9
`5.87 VB
`10
`6.76 BB
`11
`7.82 BB
`12
`8.50 BB
`13.
`9.89 BV
`14
`15 10.09 VV
`
`14.120
`3.34
`0.061
`5.355
`1.57
`0.052
`101.057
`24.77
`0.062
`13.440
`2.20
`0.091
`56.805
`12.52
`0.069
`171.121
`32.89
`0.081
`47.409
`8.27
`0.089
`12.356
`2.24
`0.082
`0.089 1.32e3 7313.577
`0.078 691.48 3458.091
`0.085
`24.08
`129.711
`0.090
`7.97
`49.417
`0.082
`1.51
`8.044
`0.087
`5.33
`29.603
`0.105
`2.88
`20.953
`
`0.11
`0.04
`0.81
`0.11
`0.45
`1.37
`0.38
`0.10
`58.41
`27.62
`1.04
`0.39
`0.06
`0.24
`0.17
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`1.939303
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`HPLCO157
`
`01/30/2002
`
`9:08:55 AM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 21
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 21
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`Peak
`#
`
`:C:\HPCHEM\HPLCO157\DATA\003-0101.D
`RT
`Type Width Height
`Area
`Area
`(min)
`(min)
`[mAU*s]
`%
`
`16 10.41 VB
`17 10.89 BP
`18 12.15 PP
`19 12.66 BV
`20 12.92 VV
`21 13.21 VB
`
`38.65
`0.107
`1.29.
`0.104
`1.85
`0.116
`1.31
`0.109
`0.086 140.72
`0.164
`2.18
`
`254.861
`9.002
`14.832
`10.214
`777.889
`23.185
`
`2.04
`0.07
`0.12
`0.08
`6.21
`0.19
`
`Signal:
`
`2 DAD1 E, Sig=268,16 Ref=360,100
`
`Amount
`mg/ml
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.00000G
`0.00000G
`
`Sample Name: 70316-0011
`Name
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`[min]
`
`Area
`{mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`5.04 BB
`1
`5.54 BV
`2
`5.87 VB
`3.
`7.82 BP
`4
`5 10.40 BB
`6 12.92 BB
`7:13.21 BB
`
`2.20
`0.090
`0.083 164.74
`0.085
`8.23
`0.085
`1.15
`0.109
`4.06
`0.089
`2.99
`0.148
`1.04
`
`12.764
`888.075
`45.889
`6.638
`27.613
`17.188
`9.788
`
`1.27
`88.11
`4.55
`0.66
`2.74
`1.71
`0.97
`
`0.000006
`1.939303
`0.000000
`0.000000
`0.000000
`0.000006
`0.00000C
`
`L-224,715
`
`*** End of Report ***
`
`HPLC0157
`
`01/30/2002
`
`9:08:55 AM
`
`Page 2 of 2:
`Merck Exhibit 2129, Page 22
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 22
`Mylan v. Merck, IPR2020-00040
`
`
`
`NO. 1
`
`MLW.
`
`STRUCTURAL FORMULA:
`
`EMPIRICAL FORMULA:
`
`__-_
`
`CATALYST
`SGLVENT
`” MOLES OF HYDROGEN REQUIRED
`OTHER MATERIALS
`
`.
`
`G.
`
`OF
`
`e{ yc
`
`ky et
`
`ML. OF
`~~
`
`G. MOLES
`
`.
`
`2002012956.001
`
`1/29/02
`
`- 1/30/02
`
`200201 2956.00 (
`HYDROGENATIONOR HIGH PRESSURE REACTION
`
`EXT. CSS52
`DATE 2 d ames?
`UESTED BY Hes LA
`AVN AIA
`BLOG/RM
`;
`ole Ge
`noTeBook-paGeNo._/:7!2
`2r~¥
`y ne
`PROJECTNO.ssPROVECT
`CHECK HEREIF REACTION IS GMP/GLP Q
`
`AMOUNT
`
`G. MOLES
`
`motes 22.00/95 Wo:
`NO.1.
`hot # LC IF 2S
`Ale
`S0°T
`OF
`CATALYST.EN CG.
`ML.
`OF
`SOLVENT
`OTHER MATERIALS
`xO m.
`VESSEL SIZE
`EXTERNAL
`REC. POINT INTERNAL —__
`CELL NO____ HEATER NO
`ML.
`SYSTEM VOLUME__7_2-—__
`SHAKER TANK
`Te
`LINER
`SHAKER NO___>. &
`LBS.
`ifs. eh.
`AOLS
`MOLES= 7: 4/
`Les/MoLeE_
`iaes_ee —————————————
`C'D H, PRESSURE DROP =
`DITIONS________ HRS. AT_ZA_ oc. misc. paTA: 4 fase e
`PRESSURE
`
`&8SSESS RUN BY } Asay DATE linn 94 Nand
`
`Ste ott
`
`REACTION CONDITIONS, ETC.
`“
`2
`
`PRECAUTIONS:
`
`BOMB NO.
`AUX. TANK
`
`DROP
`
`T
`
`01:33
`01:48
`02:03
`02:18
`02:33
`02:48
`03:03
`
`MERCK & CO., INC.
`RRALO REV FURR
`
`RUN BY
`
`DATE —
`
`Merck Exhibit 2129, Page 23
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 23
`Mylan v. Merck, IPR2020-00040
`
`
`
`1/29/02
`
`ShkrS6 Pressr
`Shkr56 H2 Uptake
`ShkrS6 Product Temp
`
`9:17.54
`1129/02
`
`13:48:01
`1429102
`
`Hist.FIX.PTS607.F_CV
`Hist.FIXDTS609.F_CV
`Mist.FIX.TES603.F_CV
`
`2002012956.001
`
`Ce
`
`18:18:08
`1129/02
`
`2248-15
`
`Merck Exhibit 2129, Page 24
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 24
`Mylan v. Merck, IPR2020-00040
`
`
`
`2002012856.001
`
`1/28/02
`
`- 1/29/02
`
`Qco2ol Afb-00 |
`HYDROGENATION OR HIGH PRESSURE REACTION
`DUESTED BY Howey siogam—“OVPAUL ite pate2
`PROJECTNO_=2'')ssprovect—_adeMiBForeBo0x-paceno/2=e")
`7
`1 a
`TNA CO
`CHECK HERE IF REACTION IS GMP/GLP O
`ING
`MATERIA’
`
`7
`
`q
`
`NO.1 NO. 2
`
`Mw.2 AMOUNT7.+ G.eMotes_/_sdMW. Ls AMOUNT CG. MOLES
`
`STRUCTURAL FORMULA:
`.
`SN Ae
`;
`LoS ALsa,
`‘ee
`Looky
`
`CATALYST
`sovent
`MOLES OF HYDROGEN REQUIRED
`OTHER MATERIALS
`*
`‘
`‘
`-K\ 4
`REACTION CONDITIONS, ETC.
`Fea
`
`PRECAUTIONS:
`
` TO BE FILLED IN BY HYDROGENATION LABORATORY
`
`noi22 Og CMs 2HOIS noe,—ts MoS
`
`catatyst___—*@JGOOg. of 4 Zed di fH -CYTAS6
`
`yc20)
`SOLVENT ML.
`OOF
`
`
`OTHER MATERIALS
`
`CELL NO.____ HEATERNO.
`REC. POINT INTERNAL ____ EXTERNAL_______ BOMB NO________vessecsize____%0 mt.
`SHAKER NO___24 LINER __________ SHAKER TANK AUX. TANK _______ SYSTEM VOLUME_7% ML.
`CDH, pressure DROP= 79.9 eso20/5 Motes ZY as,
`BNpITIONS________ srs. at_f4+
`oc. misc. paTA:
`“%_- Atm He.
`
`oe|
`
`TIME
`
`TEM
`
`ase DRCPaeeDRoF
`BSSSSESSEZ
`
`EMPIRICAL FORMULA:
` MERCK & CO., INC.
`40
`
`TEMP.
`
`DROP
`
`DDMMDDMDDMDMDDADWDOnN™
`
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`
`R-ASLA REV GAR
`
`RUN BY Uli DATE Vn 25 2a
`RUN BY
`DATE
`
`Merck Exhibit 2129, Page 25
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 25
`Mylan v. Merck, IPR2020-00040
`
`
`
`2002012856.001
`
`ShkrS6 Product Temp
`
`Hist.FIX PT5607.F_CV
`Hist.FiX.OTS609.F_CV
`Hist.FIX.TE5603.F_CV
`
`18:46:38
`1/28/02
`
`Shkr56 Pressr
`Shkr56 H2 Uptake
`
`Merck Exhibit 2129, Page 26
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 26
`Mylan v. Merck, IPR2020-00040
`
`
`
`2002013056.001
`
`1/30/02
`
`- 1/31/02
`
`20040130 56-60 |
`HYDROGENATION OR HIGH PRESSURE REACTION
`DATE wy nan 2092.
`EXT. OSs2
`Foo ck22G 4q
`I
`PROJECT NO_L22T7IS——pRovecT —Mvcoealy NOTEBOOK - PAGE NO._} 9 3te~ 08
`CHECK HERE IF REACTION IS GMP/GLP ©
`—STARTING
`
`NO. 1
`
`«(MOLES
`MLW. 31s AMOUNT _—15O G. moves.5 WwW. AMOUNT CG.
`fa. PAIS
`STRUCTURAL FORMULA:
`cataryst___O./5 ig.
`OF
`SOLVENT a. oF—_AT
`t
`Daav
`MOLES OF HYDROGEN REQUIRED
`yOmeorN
`J Bm
`OTHERMATERIALS
`~~ mm
`:
`-_
`
`. ‘ow,
`
`F
`
`ON
`+
`3
`
`Lot wl wlal THE
`
`REACTION CONDITIONS,ETC.
`oPSa
`,
`
`i
`
`;
`SVC
`
`EMPIRICAL FORMULA:
`
`PRECAUTIONS:
`3
`hi
`2% aN, 2F,
`TO BE FILLED IN BY HYDROGENATION LABORATORY
`
`notFIO ce. mores 20045 no
`CATALYsT____OIG og.
`or LOH
`/,
`—
`SOLVENT. OOF A
`OTHER MATERIALS
`
`CELL NO._____ HEATERNO. REC. POINT INTERNAL _____ EXTERNAL ____s BOMB NOW VESSEL size___0_ML.
`SHAKER NO___944 LINER ____s SHAKER TANK AUX. TANK ___ SYSTEM VOLUME_“72-—_ ML.
`
`C'DH, PRESSURE DROR=—GFDB.tesimore_O-OO/SSMS ZH LBS.
`
`pitions__Jf HRS. AT_~S@ c. MISC. DATA: VO,
`
`MATERIAL_
`
`~~ | DROFeeDROP
`eepeee
`
`TIME
`
`TEMP
`
`00000000000O
`
`Q0000 111tiai
`
`]51
`
`]
`LJ
`
`ff
`
`l
`
`‘oo
`
`1
`
`1]
`Ul
`
`RARLA REV RRR
`MERCK&CO., INC.
`
`RUNBy { WbudsrTe la. Fo atl
`RUN BY
`
`Merck Exhibit 2129, Page 27
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 27
`Mylan v. Merck, IPR2020-00040
`
`
`
`2002013056.001
`
`
`
`8.46'18
`1430/02
`
`13:16:25
`1/30/02
`
`17:46:32
`1/30/02
`
`(30/02
`
`2:46:47
`1/31/02
`
`Shki56 Product Temp
`
`Hist.FIX.PTS607.F_CV
`Hist FIX.DTS609.F_CV
`i
`
`ShkrS6 Pressr
`Shkr56 H2 Uptake
`
`3
`
`Merck Exhibit 2129, Page 28
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 28
`Mylan v. Merck, IPR2020-00040
`
`
`
`
`
`=NNNNNNNNNNRNONORRKDDDNONRNNDRONOND
`
`2002013055.001
`
`1/30/02
`
`HYDROGENATION OR HIGH PRESSURE REACTION
`
`aa
`fo BRET
`H~>¢4
`UESTED BY
`BLDG/RM
`ext. OS5Z
`pate
`_30 dan 2eve
`prosectno._*_2247!5_ provect
`M b00 AAS
`NOTEBOOK- PAGE NO. 2°3(§-0|
`
`CHECK HERE IF REACTION IS GMP/GLP OMATERIAL__—-STARTING
`
`
`2
`
`NO.1
`
`S53 amount 259 sg. motes
`
`AMOUNT
`
`G. MOLES
`
`STRUCTURAL FORMULA:
`
`OF
`G.
`~_
`1a
`CATALYST
`SOLVENT ________-/2_ ML. OF
`“MOLES OF HYDROGEN REQUIRED
`San vel
`OTHER MATERIALS
`
`12 1.PA LC
`fac o(]
`
`REACTION CONDITIONS,ETC.
`So°c HoP+
`
`EMPIRICAL FORMULA: Ci 5 If5\NPy F
`TO BE FILLED IN BY HYDROGENATION LABORATORY
`
`PRECAUTIONS:
`
`NO.2:
`
`G. MOLES
`
`G. motes _2-O0f
`(750
`NO.1:
`Gc. of L2% i
`-fS0
`CATALYST
`SOLVENT.CsCl. 8_CO
`OTHER MATERIALS
`REC. POINT INTERNAL —_____ EXTERNAL
`CELL NO.___ HEATER NO.
`SHAKER NO.LINER SHAKER TANK
`
`BOMB NO
`AUX. TANK
`
`vesset size__— OM.
`SYSTEM VOLUME_S77 ML.
`MOLES= Gy LBS.
`
`C'D H, PRESSURE DROP= 26S issmoue_O- OOS.
`BNDITIONS.___— RS. ATO.
`cc.
`isc. DATA:
`
`‘
`
`a|P
`
`TEMPteeDROP
`
`RESSURE
`
`—c
`—s
`
`TIME
`
`TEMP.
`
`DROP
`
`TIME
`
`TEMP.
`
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`40
`
`TIME
`
`NNNANNRONNONRONOOONONRDORORD
`
`MERCK&CO., INC.
`RASA REV RAR
`
`ry)
`
`RUN BY
`
`RUN BY
`
`/ DATE
`
`DATE
`
`Co
`
`2 20—
`
`Merck Exhibit 2129, Page 29
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 29
`Mylan v. Merck, IPR2020-00040
`
`
`
`2002013055.001
`
`Shk155 Pressr
`ShkrS5 H2 Uptake
`Shkr55 Product Temp
`
`Hist.F1X.PTS507.F_CV
`Hist. FIXDTSS09. F_CV
`ist.FIX.TESSO3.F_CV
`
`Merck Exhibit 2129, Page 30
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 30
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\002-0101.D
`
`Sample Name: 70316-0001
`
`hydrog after resubmission
`
`->
`
`Injection Date : 01/30/2002
`Sample Name
`: 70316-0001
`Acq Operator
`: hansen
`
`8:25:41 AM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile, 1ml/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`:
`:
`:
`
`1
`2
`1
`2 pl
`
`DAD1 C, Sig=210,8 Ref=360,100 (002-0101.D)
`
`DAD1 E, Sig=268,16 Ref=360,100 (002-0101.D)
`
`Sorted By
`Calib. Data Modified
`Multiplier —
`
`> Signal
`: 01/14/2002
`: 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DADI C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`(min]
`
`Type Width Height
`[min]
`
`Area
`{mAU*s]}
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`2.24 BB
`1
`2.48 BV
`2
`2.99 BB
`3.
`3.54 BB
`4
`5.41 PV
`5
`0.00
`6
`5.80 VB
`7
`6.69 BP
`8
`7.65 BB
`9
`10 10.31 PB
`11 12.88 BB
`12 13.27 BB
`
`9.424
`2.02
`0.070
`17.655
`4.22
`0.065
`11.327
`2.32
`0.075
`32.437
`5.67
`0.089
`0.103 234.39 1553.550
`0.000
`0.00
`0.000
`0.094 116.77
`699.888
`0.096
`4.00
`24.515
`0.113
`1.50
`12.218
`0.119
`6.59
`47.711
`0.089
`27.20
`155.375
`0.132
`1.35
`12.066
`
`0.37
`0.69
`0.44
`1.26
`60.30
`0.00
`27.17
`0.95
`0.47
`1.85
`6.03
`0.47
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`HPLCO157
`
`01/30/2002
`
`8:40:02 AM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 31
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 31
`Mylan v. Merck, IPR2020-00040
`
`
`
`:C:\HPCHEM\HPLCO157\DATA\002-0101.D
`Data file
`Signal:
`2 DAD] E, Sig=268,16 Ref=360,100
`
`Sample Name: 70316-001
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`{min]
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`1
`2
`3.
`
`5.41 BB
`0.00
`5.80 BB
`
`0.098
`0.000
`0.094
`
`26.83
`0.00
`1.34
`
`165.704
`0.000
`7.981
`
`95.41
`0.00
`4.59
`
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`*** End of Report ***
`
`HPLCO157
`
`01/30/2002
`
`8:40:02 AM
`
`Page 2 of 2
`Merck Exhibit 2129, Page 32
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 32
`Mylan v. Merck, IPR2020-00040
`
`
`
`
`
`ayerTAseqSTLpZZ7
`
`
`
`200prwuU¢ET-9
`
`mrOMEeHCsINEPDH~)OOCOWOMHbF-
`
`11oonoooOOoWwWWw1COFFDRWwWLO
`
`WWWWwwPPSPSP
`
`A(1ISSs\
`
`@° LTT-———_
`S°6TT——_
`
`0° S@T—_
`1 8el ——
`L°6¢1——_—
`
`L°S¥1——_
`
`9° 0ST————
`
`6° 69T
`
`propretees
`
`09
`
`08
`
`00T
`
`Oct
`
`OvT
`
`09T
`
`O8T
`
`002
`
`
`
`
`
`
`
`
`
`sasssstssom===esTANNYHO====222=====
`
`=ssssssss====[TJTHNNWHO============
`
`wo/udd90062°9WONdd
`
`WO/ZH£8678829WOZH
`
`995n00°S6?@ddod
`
`
`
`
`qoadsWOYLSNI opbzoudNd CTOLNHATOS ZH€6p00P0Saudld C618ouoesn0S0°6TMdo9sn00°9ad oasn0S°ZTQETTOANT/HTdNOuN¢=GHaOud
`
`wdd900°0F2dtd
`
`wdd000‘0T-dd
`
`ZHN96LL21900Tgs
`ZHWLOOZCET007cOdS
`
`98S0000000T'0TdM0°O00€ab
`985000000€0'0TTP
`
`ZHNP96LEC9 O0TToads
`
`
`28SBOTS8IC'Tow
`
`
`SisJoWeseguotTstnboy-fd
`wo00°0FXO
`ZHLOLOTPZTd
`ZH€T'900T-ca
`dP00°8Teld
`aP00°02T71d
`siajeweiedBursse.0rg-2d
`
`
`ZH00°Ta10ass
`ae00°017
`ZH61L99797HMS0sa
`WaMdm
`Or'Tod0gd
`HTCONN
`gTzqTeMmcOudddd
`
`89L7EIS
`
`szajaueregejeqyuerIND
`
`TOO-9TEOLaNVN
`0T2SN
`9€S59aL
`02°Laut]
`
`10202002~a3eq
`TONOOUdéONdXd
`szajewezedj0TdYNGT
`
`022wdd
`
`
`
`
`
`
`
`
`
`
`
`Merck Exhibit 2129, Page 33
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 33
`Mylan v. Merck, IPR2020-00040
`
`
`
`
`
`
`
`4[esaqeTAsaqpajerost
`
`TY9007ruu
`
`
`
`Merck Exhibit 2129, Page 34
`Mylan v. Merck, IPR2020-00040
`
`|
`
`+0ass
`
`ZHW9SQ00€T'00Pas
`
`p8CoTIs
`
`ouMM
`
`wo00°09XO
`
`Sleqewezed07dWNAT
`
`
`
`wdd9SL°6did
`
`ZHLZT06€Td
`
`
`
`wdd9¢z‘0-dz
`
`ZH€0°00T-cd
`
`
`
`wo/wdd00052°0WONdd
`
`
`
`wo/ZH0SZ€0'00TWOZH
`
`ZH00°0qi
`
`00°Tod0a)
`
`
`
`siajeuezeguotIstnboy-74
`
`
`
`10202002“a7ed
`
`OTLsuTL
`
`
`
`qoadsWOMLSNI
`
`T/HTdNOwu¢aHd0ud
`
`o¢b2)0udInd
`
`B9LZEaL
`
`NO€GOLNAATOS
`
`ceSN
`
`
`
`98S9TL69692ow
`
`Geeou
`
`
`
`o9sn00C°9LMa
`
`
`
`o9sn00°9ad
`
`
`
`22850000000T0Td40°00€ab
`
`
`
`ZH089°1999HMScsd
`
`
`
`ZHLb72007'0Saudia
`
`
`
`TOO-9TEOLSWVN
`
`TONDOUdTONdXd
`
`
`
`
`
`2orrccssssssfs==TI‘TENNWHOssssssssssss
`
`
`
`oesnQ0°0TTa
`
`ap00°S-TI
`
`ZHNLOOZZET00FTod"
`
`HTTONN
`
`
`
`
`
`SJejaweiedHutssas0rg-7d
`
`
`
`
`
`siajewelegeyeqyuaezIND
`
`Merck Exhibit 2129, Page 34
`Mylan v. Merck, IPR2020-00040
`
`
`
`
`Book
`
`7031 6
`
`Page
`
`3
`
`ProjectNo... Project Page
`y
`on
`Investigator— Date> Jan2o2
`
`Subject,RE
`Filed in Book Number/Title
`
`
`
`.
`
`F
`
`Nit, .
`j
`Spee
`cz
`
`LALA.
`2A
`L—Tetadte nc i L< 7S
`ra
`
`&
`
`Ew
`ot
`So
`
`shulho
`
`L224 1S-LTachak salt
`
`on ~- |
`A+
`|$0-— 0, 369
`$62, O14 6, 301
`1m
`
`2
`1.02
`
`a Sole a /S¢
`ol
`TBMc per d
`A LAA
`Pr ocelMce '
`
`
`
`KT 5722YTRADS CAS i well road lw2 aka oChr 6
`
`
`
`
`
`
`27|Rosr-sels yan shored s/h cask eT.
`.
`PAn-cA
`t
`e@ Yo ul No snefnis
`. eS
`.
`1 90 alh A
`Lie.
`IA,
`nv San,
`Dy DR!
`A “Rh S,
`
`wh